Home Biofeedback Therapy for Bowel and Urinary Incontinence
(Bioanatoner Trial)
Trial Summary
What is the purpose of this trial?
Biofeedback therapy is an effective treatment for the management of patients with dyssynergic defecation and constipation, urinary incontinence (UI), and fecal incontinence (FI). It is labor-intensive, costly, requires multiple office or hospital visits, is not easily available to the vast majority of patients in the community, and is not covered by many insurance companies. The purpose of this study is to 1. Evaluate home biofeedback therapy for patients with either constipation and dyssynergic defecation or urinary leakage or stool leakage by assessing the efficacy and safety of a wireless anorectal biofeedback device, and a cellphone app-based and voice guided home biofeedback training system 2. To compare the efficacy and safety of home biofeedback therapy system with the standard of care, office biofeedback therapy 3. To assess the cost-effectiveness of home biofeedback therapy.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are using opioids, you must not have used them in the past two weeks for constipation and dyssynergic defecation, or you must be on a stable dose for more than three months for fecal incontinence.
What data supports the effectiveness of the treatment Home Biofeedback Therapy for Bowel and Urinary Incontinence?
Research shows that biofeedback therapy can be effective for managing pelvic floor disorders and fecal incontinence, with about 60% of patients experiencing long-term improvement. Additionally, combining biofeedback with physiotherapy has shown better results for urinary incontinence compared to physiotherapy alone.12345
Is home biofeedback therapy safe for treating bowel and urinary incontinence?
How is home biofeedback therapy different from other treatments for bowel and urinary incontinence?
Home biofeedback therapy is unique because it allows patients to manage their bowel and urinary incontinence at home using technology, making it more accessible and less resource-intensive than traditional office-based biofeedback therapy. This approach is particularly beneficial for younger patients who are comfortable with technology and prefer self-management.1451011
Research Team
Satish Rao, MD, PhD
Principal Investigator
Augusta University
Eligibility Criteria
This trial is for individuals with bowel or urinary incontinence, or bedwetting. Participants must have had symptoms for several months and meet specific diary criteria. Those with constipation need to fit the Rome IV criteria and show a certain pattern on tests. People can't join if they have related structural diseases, severe health conditions, are using opioids recently, or are pregnant/nursing.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Home Biofeedback Therapy (HBT) or Office Biofeedback Therapy (OBT) for 6 weeks. HBT involves daily practice at home, while OBT involves weekly office visits.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments at 6 and 12 weeks.
Long-term Follow-up
Participants are monitored for long-term outcomes, including the number of complete spontaneous bowel movements and episodes of fecal and urinary incontinence.
Treatment Details
Interventions
- Home Biofeedback therapy
- Office biofeedback therapy
Home Biofeedback therapy is already approved in United States, European Union for the following indications:
- Dyssynergic Defecation
- Constipation
- Urinary Incontinence
- Fecal Incontinence
- Fecal Incontinence
- Constipation
- Urinary Incontinence
Find a Clinic Near You
Who Is Running the Clinical Trial?
Augusta University
Lead Sponsor